Proton MR and Human Cervical Neoplasia: Ex Vivo Spectroscopy Allows Distinction of Invasive Carcinoma of the Cervix from Carcinoma in Situ and Other Preinvasive Lesions
Affiliations
The concept that high-resolution (8.5-T) hydrogen-1 magnetic resonance (MR) spectroscopy can be used as an adjunct to conventional histologic diagnosis of cervical neoplasia was investigated. Cervical biopsy specimens (n = 159) were examined with H-1 MR spectroscopy and the results compared with results of histopathologic analysis. A high-resolution lipid MR spectrum was observed in 39 of 40 invasive carcinomas, whereas the 119 preinvasive samples showed little or no lipid spectrum but were characterized by a strong unresolved resonance between 3.8 and 4.2 ppm. Peak ratios of the methylene/methyl and the unresolved/methylene resonances allowed accurate distinction between invasive and preinvasive epithelial malignancy (P < .0001). Since MR spectroscopic examination does not destroy the specimen, the specimens remained intact for further testing and histopathologic analysis. The authors conclude that H-1 MR spectroscopy can independently allow distinction between invasive and preinvasive lesions of the cervix and has the potential to assist in clinical management of cervical cancer.
Ibrahim Amin M, Amin A, Badr S, Ebaid N Pol J Radiol. 2024; 89:e378-e385.
PMID: 39257922 PMC: 11384214. DOI: 10.5114/pjr/190840.
Utilization of functional MRI in the diagnosis and management of cervical cancer.
Matani H, Patel A, Horne Z, Beriwal S Front Oncol. 2022; 12:1030967.
PMID: 36439416 PMC: 9691646. DOI: 10.3389/fonc.2022.1030967.
The contribution of the H-MRS lipid signal to cervical cancer prognosis: a preliminary study.
Dolciami M, Canese R, Testa C, Pernazza A, Santangelo G, Palaia I Eur Radiol Exp. 2022; 6(1):47.
PMID: 36184731 PMC: 9527268. DOI: 10.1186/s41747-022-00300-1.
Proton magnetic resonance spectroscopy of lung cancer .
Fujimoto S, Minato K, Horikoshi H, Suga S, Sato M, Mashimo K Radiol Case Rep. 2020; 15(7):1099-1102.
PMID: 32489513 PMC: 7256246. DOI: 10.1016/j.radcr.2020.05.018.
Proton MRS of cervical cancer at 7 T.
Arteaga de Castro C, Hoogendam J, van Kalleveen I, Raaijmakers A, Zweemer R, Verheijen R NMR Biomed. 2018; 32(1):e4015.
PMID: 30376201 PMC: 6588007. DOI: 10.1002/nbm.4015.